| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/22/1992 | US5149716 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
| 09/22/1992 | US5149537 Suppository form; reducing calcium levels in blood; taurocholic acid as enhancer for calcitonin |
| 09/20/1992 | WO1992016224A1 Improved fish production |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
| 09/17/1992 | WO1992015592A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION |
| 09/17/1992 | WO1992015313A1 Lowering blood cholesterol levels using cellulose ethers |
| 09/17/1992 | WO1992015312A1 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
| 09/17/1992 | WO1992015292A1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 09/17/1992 | WO1992012960A3 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 09/16/1992 | WO1992016222A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 09/16/1992 | EP0504055A1 Compositions comprising glucides for use in diet and therapy, and their uses |
| 09/16/1992 | EP0503827A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/16/1992 | EP0503520A1 Cyclic ketal derivatives |
| 09/16/1992 | EP0503496A1 Lowering blood cholesterol levels using cellulose ethers |
| 09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
| 09/16/1992 | CA2063005A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/15/1992 | US5147879 O-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 09/15/1992 | US5147878 Hypotensive, antiarrhythmia agents |
| 09/15/1992 | US5147870 Antilepemic, anticholesterol agents |
| 09/15/1992 | US5147857 Glycolic acid derivatives |
| 09/15/1992 | CA1307537C N-naphthoylglycines as aldose reductase inhibitors |
| 09/14/1992 | WO1992016276A1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
| 09/14/1992 | CA2104232A1 Process for purification of hmg-coa reductase inhibitors |
| 09/14/1992 | CA2062920A1 Compositions containing a special combination of carbohydrates to be utilized in dietetics and therapeutics, and their applications |
| 09/13/1992 | WO1992016530A1 Cyclic ketal derivatives |
| 09/13/1992 | CA2106072A1 Cyclic ketal derivatives |
| 09/09/1992 | WO1992015579A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | EP0502709A1 Gallium compounds |
| 09/09/1992 | EP0502666A1 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
| 09/09/1992 | EP0502498A1 Phenoxyalkanoic acid derivatives and process for preparation thereof |
| 09/09/1992 | EP0502392A1 Process for the preparation of D-(+)-biotin and intermediates in this process |
| 09/09/1992 | EP0502357A1 Optically active and racemic hydrated diacetylesters of alpha-glycero-phosphoryl-choline |
| 09/09/1992 | EP0502313A2 Method for insuring adequate intracellular glutathione in tissue |
| 09/09/1992 | EP0502188A1 Cloned glutamic acid decarboxylase |
| 09/09/1992 | EP0502075A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 09/09/1992 | EP0502007A1 Arginine nicotinate for reducing blood cholesterol |
| 09/09/1992 | EP0382720B1 Diagnosing obesity caused by a genetic abnormality and method of therapeutically treating genetically caused obesity |
| 09/09/1992 | CN1064313A Realignment protein of human digestive enzyme and process for their preparation |
| 09/09/1992 | CA2105655A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | CA2062437A1 Acyclamenophenol derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them |
| 09/08/1992 | US5145865 Phenylcarboxylic acid derivatives having hetero ring |
| 09/08/1992 | US5145857 Hmg-coa reductase-inhibiting substituted amino-pyridines |
| 09/08/1992 | US5145611 Diabetes |
| 09/08/1992 | CA2061643A1 Optically active and racemic hydrated diacetylesters of .alpha.-glycero-phosphoryl-choline |
| 09/08/1992 | CA1307267C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307266C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307265C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307263C Hmg-coa reductase inhibitors |
| 09/07/1992 | CA2061653A1 Oral gallium complexes |
| 09/06/1992 | WO1992015546A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 09/06/1992 | CA2105571A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 09/03/1992 | WO1992014754A1 Process for the phosphorylation of insulin and product produced thereby |
| 09/03/1992 | WO1992014730A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 09/03/1992 | WO1992014719A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 09/03/1992 | WO1992014445A1 Sustained drug release through topical application of bioadhesive liposomes |
| 09/03/1992 | CA2081112A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500713A1 New derivatives of 3,3,5-trimethylcyclohexanol methyl-2 propionate, preparation method and therapeutical compositions containing them |
| 09/01/1992 | US5144029 Derivatives of 1-[3-(4-hydroxyphenyl) 1-hydroxy 1-propyl] benzene substituted in position 2 by an aminoalkyleneoxy chain, the method of preparing same and the application thereof to therapeutics |
| 09/01/1992 | US5143937 Treatment of hyperlipidemia |
| 09/01/1992 | US5143907 Phosphite-borane compounds, and method of making and using the same |
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
| 08/26/1992 | EP0500426A1 2,6-Dimethyl-4-(4'-hydroxy-3',5'-di-t-butylphenyl)-1,4-dihydropyridine derivatives, process for their preparation and their use as free radical scavengers |
| 08/26/1992 | EP0500348A1 Disubstituted ureas and thioureas |
| 08/26/1992 | EP0500337A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes |
| 08/26/1992 | EP0500336A1 Composition containing certain phenol and benzamide for the treatment of type I diabetes |
| 08/26/1992 | EP0499679A1 Therapeutic agent for diabetic gangrene |
| 08/26/1992 | CN1017992B Process for preparing piperidine opioid antagonists |
| 08/25/1992 | US5142094 Anticholesterola gents |
| 08/25/1992 | US5142053 Process for the preparation of 1-(2,3,4-trimethoxybenzyl)piperazine by reductive animation |
| 08/25/1992 | US5141937 Treatment of hyperlipidemias |
| 08/25/1992 | CA1306747C Process for the preparation of new heterocyclic derivatives which can be used especially as aldose reductase inhibitors |
| 08/23/1992 | CA2061363A1 Method of treating type i diabetes |
| 08/23/1992 | CA2061340A1 Method of treating type i diabetes |
| 08/20/1992 | WO1992013880A1 Novel peptide |
| 08/20/1992 | WO1992013864A1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/20/1992 | WO1992013543A1 Method for extracting a biological substance from lepidoptera larvas and substance thus obtained |
| 08/20/1992 | CA2061447A1 Disubstituted ureas and thioureas derivatives |
| 08/19/1992 | EP0288478B1 Use of growth hormone for nitrogen retention under hypocaloric conditions |
| 08/19/1992 | CN1063685A Calcium uptake inhibitors |
| 08/19/1992 | CN1017897B Dihydropyridine derivatives, their preparation and their use |
| 08/18/1992 | US5140038 Thromboxane A2 antagonists |
| 08/18/1992 | US5139481 Treatment for type II diabetes |
| 08/12/1992 | EP0498588A1 Use of tenidap to reduce total serum cholesterol, LDL cholesterol and triglycerides |
| 08/12/1992 | EP0498466A1 Indazole-3-carboxamide and -3-carboxylic acid derivatives |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/12/1992 | EP0497845A1 Bafilomycine macrolides for treatment of bone affecting diseases |
| 08/12/1992 | EP0497771A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 08/11/1992 | US5138090 Substituted biphenyls |
| 08/11/1992 | US5138058 Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof |
| 08/11/1992 | US5137921 Conduritol A, a monosaccharide; affects intestinal absorption |
| 08/11/1992 | US5137909 Indole derivative and method of production thereof |
| 08/11/1992 | US5137891 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones |
| 08/11/1992 | US5137881 Anticholesterol, antilipemic agents |
| 08/11/1992 | US5137871 Treatment to reduce edema for brain and musculature injuries |
| 08/06/1992 | WO1992013086A1 Arachidonic acid and methods for the production and use thereof |
| 08/06/1992 | WO1992012990A1 14,16β-ETHANO-15β,161 -CYCLO-14β-ESTRA-1,3,5(10)-TRIENES |